Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Np, Michael"'
Autor:
Nk, Green, Dj, Youngs, John Neoptolemos, Friedlos F, Rj, Knox, Cj, Springer, Gm, Anlezark, Np, Michael, Rg, Melton, Mj, Ford, Ls, Young, Dj, Kerr, Pf, Searle
Publikováno v:
Europe PubMed Central
Expression of genes encoding prodrug-activating enzymes can increase the susceptibility of tumor cells to prodrugs, and may ultimately achieve a better therapeutic index than conventional chemotherapy. CB1954 is a weak, monofunctional alkylating agen
Autor:
Michael NP; University of Akron, Akron, OH, USA npm19@zips.uakron.edu., Torres R; Universidad Nacional Autónoma de México, México City, México., Welch AJ; Durham University, Durham, UK., Adams J; United States Geological Survey, Western Ecology Research Center, Santa Cruz, CA, USA., Bonillas-Monge ME; Durham University, Durham, UK., Felis J; United States Geological Survey, Western Ecology Research Center, Santa Cruz, CA, USA., Lopez-Marquez L; Universidad Nacional Autónoma de México, México City, México., Martínez-Flores A; Universidad Nacional Autónoma de México, México City, México., Wiley AE; University of Akron, Akron, OH, USA.
Publikováno v:
Biology letters [Biol Lett] 2018 Sep 26; Vol. 14 (9). Date of Electronic Publication: 2018 Sep 26.
Autor:
Sharma SK; CR UK Targeting and Imaging Group, Department of Oncology, Royal Free and University College Medical School, Royal Free Campus, Rowland Hill Street, London NW3 2PF, United Kingdom. surinder.sharma@ucl.ac.uk, Pedley RB, Bhatia J, Boxer GM, El-Emir E, Qureshi U, Tolner B, Lowe H, Michael NP, Minton N, Begent RH, Chester KA
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2005 Jan 15; Vol. 11 (2 Pt 1), pp. 814-25.
Autor:
Adie EJ; Bioassays, Development, Amersham Biosciences, Whitchurch, Cardiff, United Kingdom. Elaine.Adie@uk.amershambiosciences.com, Francis MJ, Davies J, Smith L, Marenghi A, Hather C, Hadingham K, Michael NP, Milligan G, Game S
Publikováno v:
Assay and drug development technologies [Assay Drug Dev Technol] 2003 Apr; Vol. 1 (2), pp. 251-9.
Autor:
Adie EJ; Amersham Biosciences, Whitchurch, Cardiff, UK. elaine.adie@uk.amershambiosciences.com, Kalinka S, Smith L, Francis MJ, Marenghi A, Cooper ME, Briggs M, Michael NP, Milligan G, Game S
Publikováno v:
BioTechniques [Biotechniques] 2002 Nov; Vol. 33 (5), pp. 1152-4, 1156-7.
Autor:
Spencer DI; CRC Targeting and Imaging Group, Department of Oncology, Royal Free and University College Medical School, UCL, London, UK., Robson L, Purdy D, Whitelegg NR, Michael NP, Bhatia J, Sharma SK, Rees AR, Minton NP, Begent RH, Chester KA
Publikováno v:
Proteomics [Proteomics] 2002 Mar; Vol. 2 (3), pp. 271-9.
Autor:
Bhatia J; Department of Oncology, Royal Free and University College Medical School, London, UK. jeet@rfhsm.ac.uk, Sharma SK, Chester KA, Pedley RB, Boden RW, Read DA, Boxer GM, Michael NP, Begent RH
Publikováno v:
International journal of cancer [Int J Cancer] 2000 Feb 15; Vol. 85 (4), pp. 571-7.
Autor:
Green NK; Department of Surgery, University of Birmingham, UK., Youngs DJ, Neoptolemos JP, Friedlos F, Knox RJ, Springer CJ, Anlezark GM, Michael NP, Melton RG, Ford MJ, Young LS, Kerr DJ, Searle PF
Publikováno v:
Cancer gene therapy [Cancer Gene Ther] 1997 Jul-Aug; Vol. 4 (4), pp. 229-38.
Autor:
Michael NP; Department of Molecular Microbiology, Centre for Applied Microbiology and Research, Wiltshire, UK., Chester KA, Melton RG, Robson L, Nicholas W, Boden JA, Pedley RB, Begent RH, Sherwood RF, Minton NP
Publikováno v:
Immunotechnology : an international journal of immunological engineering [Immunotechnology] 1996 Feb; Vol. 2 (1), pp. 47-57.
Autor:
Bridgewater JA; CRC Centre for Cell and Molecular Biology, Chester Beatty Laboratories, London, UK., Springer CJ, Knox RJ, Minton NP, Michael NP, Collins MK
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 1995 Dec; Vol. 31A (13-14), pp. 2362-70.